Market Place
Sourcing Support
Recipharm completes US biologics acquisitions
11 Apr 2022 //
PRESS RELEASE
Vibalogics Completes Milestone in $50M Cuxhaven Facility Expansion
08 Mar 2022 //
CONTRACTPHARMA
Swedish CDMO Recipharm is absording Arranta Bio and Vibalogics
19 Feb 2022 //
FIERCEPHARMA
Vibalogics Advances Growth with Leadership Hires
15 Jul 2021 //
CONTRACT PHARMA
Viral manufacturer Vibalogics plots out expansion at German site
16 Jun 2021 //
ENDPTS
Vibalogics Expands Manufacturing Capacity
11 Jun 2021 //
CONTRACTPHARMA
Vibalogics Expands Manufacturing Capacity
11 Jun 2021 //
CONTRACT PHARMA
Vibalogics spending $50M on viral vector capacity in Germany
11 Jun 2021 //
FIERCE PHARMA
CDMO Vibalogics, speeding toward U.S. commercial plant
10 Jun 2021 //
FIERCEPHARMA
Vibalogics Updates U.S. Leadership Team
31 Mar 2021 //
CONTRACTPHARMA
Vibalogics Establishes US Presence with Boston Virotherapy mfg Facility
16 Nov 2020 //
PHARMTECH
Vibalogics Establishes U.S. Presence With Virotherapy Facility In Boston
11 Nov 2020 //
OUTSOURCINGPHARMA
Viral vector manufacturer Vibalogics adds CEO to lead expansion
21 Sep 2020 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.